Clinical Trial Update: Varenicline Treatment for Smoking Cessation in Patients With Bipolar Disorder [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update reports results of varenicline for smoking cessation in patients with bipolar disorder, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Varenicline (Chantix) (varenicline)

Snippet

Sponsor: K.N. Roy Chengappa | Conditions: Smoking Cessation, Bipolar Disorder | Phase 4 | Status: COMPLETED | Results posted: 2015-03-12